Vaccinex Inc USD0.0001

Sell:$0.90Buy:$0.90$0.07 (8.09%)

Prices delayed by at least 15 minutes
Sell:$0.90
Buy:$0.90
Change:$0.07 (8.09%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.90
Buy:$0.90
Change:$0.07 (8.09%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop pepinemab for the treatment of various diseases and conditions, including cancer. ActivMAb antibody discovery platform is a human antibody discovery platform based on a method for expressing multipass membrane proteins, as well as large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of mammalian pox viruses.

Key people

Albert D. Friedberg
Chairman of the Board
Maurice Zauderer
President, Chief Executive Officer, Director
Jill Sanchez
Interim Chief Financial Officer
Elizabeth E. Evans
Chief Operating Officer, Senior Vice President - Discovery and Translational Medicine
Ernest S. Smith
Senior Vice President - Research, Chief Scientific Officer
John E. Leonard
Senior Vice President - Development
Jacob B. Frieberg
Independent Director
Gerald E. Van Strydonck
Independent Director
Barbara Yanni
Independent Director
Click to see more

Key facts

  • EPIC
    VCNX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US9186403013
  • Market cap
    $2.03m
  • Employees
    23
  • Shares in issue
    2.68m
  • Exchange
    Over The Counter
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.